BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
Public ClinicalTrials.gov record NCT05142436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BAT3221032: A Randomized, Controlled Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, controlled, multi-center, open-label, 8-cohort parallel group study to assess changes in select biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in generally healthy smokers switching to the study investigational products (IPs), compared to subjects who continue to smoke, undergo smoking abstinence, or have never smoked.
Study identification
- NCT ID
- NCT05142436
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 806 participants
Conditions and interventions
Conditions
Interventions
- Product A: Non-Combusted Cigarette Variant 42001402 and product use Mode B Other
- Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B Other
- Product C: Non-Combusted Cigarette Variant 42001401 and product use Mode B Other
- Product D: Non-Combusted Cigarette Variant 40007386 and product use Mode B Other
- Product E: Non-Combusted Cigarette Variant 42001402 and product use Mode A Other
Other
Eligibility (public fields only)
- Age range
- 26 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 13, 2022 (Actual)
- Primary completion
- Dec 13, 2022 (Actual)
- Completion
- Dec 13, 2022 (Actual)
- Last update posted
- Dec 16, 2022
2022
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pillar Clinical Research, LLC | Bentonville | Arkansas | 72712 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest | Rogers | Arkansas | 72758 | — |
| Bright Research Center | Miami | Florida | 33144 | — |
| Infinite Clinical Trials | Morrow | Georgia | 30260 | — |
| AMR Lexington | Lexington | Kentucky | 40509 | — |
| AMR Kansas City | Kansas City | Missouri | 64114 | — |
| QPS Bio-Kinetic | Springfield | Missouri | 65802 | — |
| High Point Clinical Trials Center | High Point | North Carolina | 27265 | — |
| Monroe Biomedical Research | Monroe | North Carolina | 28112 | — |
| M3 Wake Research, Inc. | Raleigh | North Carolina | 27612 | — |
| Centricity Research | Columbus | Ohio | 43213 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | — |
| AMR Knoxville | Knoxville | Tennessee | 37920 | — |
| InSite Clinical Research, LLC. | DeSoto | Texas | 75115 | — |
| Pillar Clinical Research | Richardson | Texas | 75080 | — |
| Clinical Trials of Texas | San Antonio | Texas | 78229 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05142436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05142436 live on ClinicalTrials.gov.